Interaction between GSTM1 genotype and IL-6 on mortality in older adults: Results from the ilSIRENTE study

Cytokine

Volumn 53, Issue 3, 2011, Pages 301-305

  Onder, Graziano ^a   Capoluongo, Ettore ^a   Giovannini, Silvia ^a   Concolino, Paola ^a   Russo, Andrea ^a   Liperoti, Rosa ^a   Bernabei, Roberto ^a   Landi, Francesco ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

GSTM1; IL 6; Older adults

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; INTERLEUKIN 6;

AGE; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SEX RATIO; WILD TYPE;

AGED, 80 AND OVER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; INFLAMMATION; INTERLEUKIN-6; ITALY; KAPLAN-MEIER ESTIMATE; MALE; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 79251644426     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2010.11.020     Document Type: Article

References (34)

1. Finkel T., Holbrook N.J. Oxidants, oxidative stress and the biology of aging. Nature 2000, 408:239-247.
2. Yu B.P., Chung H.Y. Adaptive mechanisms to oxidative stress during aging. Mech Ageing Dev 2006, 127:436-443.
3. Sastre J., Pallardó F.V., García de la Asunción J., Viña J. Mitochondria, oxidative stress and aging. Free Radic Res 2000, 32:189-198.
4. Williams J.B., Roberts S.P., Elekonich M.M. Age and natural metabolically-intensive behavior affect oxidative stress and antioxidant mechanisms. Exp Gerontol 2008, 43:538-549.
5. Van Remmen H., Jones D.P. Current thoughts on the role of mitochondria and free radicals in the biology of aging. J Gerontol A Biol Sci Med Sci 2009, 64:171-174.
6. Fusco D., Colloca G., Lo Monaco M.R., Cesari M. Effects of antioxidant supplementation on the aging process. Clin Interv Aging 2007, 2:377-387.
7. Ketterer B. Protective role of glutathione and glutathione transferases in mutagenesis and carcinogenesis. Mutat Res 1988, 202:343-361.
8. Pemble S., Schroeder K.R., Spencer S.R., Meyer D.J., Hallier E., Bolt H.M., et al. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 1994, 300(Pt 1):271-276.
9. Geisler S.A., Olshan A.F. GSTM1, GSTT1, and the risk of squamous cell carcinoma of the head and neck: a mini-HuGE review. Am J Epidemiol 2001, 154:95-105.
10. Li R., Boerwinkle E., Olshan A.F., Chambless L.E., Pankow J.S., Tyroler H.A., et al. Glutathione S-transferase genotype as a susceptibility factor in smoking-related coronary heart disease. Atherosclerosis 2000, 149:451-462.
11. Li R., Folsom A.R., Sharrett A.R., Couper D., Bray M., Tyroler H.A. Interaction of the glutathione S-transferase genes and cigarette smoking on risk of lower extremity arterial disease: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 2001, 154:729-738.
12. Manfredi S., Federici C., Picano E., Botto N., Rizza A., Andreassi M.G. GSTM1, GSTT1 and CYP1A1 detoxification gene polymorphisms and susceptibility to smoking-related coronary artery disease: a case-only study. Mutat Res 2007, 621:106-112.
13. Leopold J.A., Loscalzo J. Oxidative risk for atherothrombotic cardiovascular disease. Free Radic Biol Med 2009, 47:1673-1706.
14. Capoluongo E., Onder G., Concolino P., Russo A., Santonocito C., Bernabei R., et al. GSTM1-null polymorphism as possible risk marker for hypertension: results from the aging and longevity study in the Sirente geographic area (ilSIRENTE study). Clin Chim Acta 2009, 399:92-96.
15. Pinhel M.A., Nakazone M.A., Cação J.C., Piteri R.C., Dantas R.T., Godoy M.F., et al. Glutathione S-transferase variants increase susceptibility for late-onset alzheimer's disease: association study and relationship with apolipoprotein E epsilon4 allele. Clin Chem Lab Med 2008, 46:439-445.
16. Perez-Pastene C., Graumann R., Díaz-Grez F., Miranda M., Venegas P., Godoy O.T., et al. Association of GST M1 null polymorphism with parkinson's disease in a chilean population with a strong amerindian genetic component. Neurosci Lett 2007, 418:181-185.
17. Capoluongo E., Almadori G., Concolino P., Bussu F., Santonocito C., Vendittelli F., et al. GSTT1 and GSTM1 allelic polymorphisms in head and neck cancer patients from Italian Lazio region. Clin Chim Acta 2007, 376:174-178.
18. Lee Y.W., Lee W.H., Kim P.H. Oxidative mechanisms of IL-4-induced IL-6 expression in vascular endothelium. Cytokine 2010, 49:73-79.
19. Chung H.Y., Cesari M., Anton S., Marzetti E., Giovannini S., Seo A.Y., et al. Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res Rev 2009, 8:18-30.
20. Dayhoff-Brannigan M., Ferrucci L., Sun K., Fried L.P., Walston J., Varadhan R., et al. Oxidative protein damage is associated with elevated serum interleukin-6 levels among older moderately to severely disabled women living in the community. J Gerontol A Biol Sci Med Sci 2008, 63:179-183.
21. Landi F., Russo A., Cesari M., Barillaro C., Onder G., Zamboni V., et al. The ilSIRENTE study: a prospective cohort study on persons aged 80years and older living in a mountain community of Central Italy. Aging Clin Exp Res 2005, 17:486-493.
22. Mangani I., Cesari M., Russo A., Onder G., Maraldi C., Zamboni V., et al. Physical function, physical activity and recent falls. Results from the " Invecchiamento e Longevità nel Sirente (ilSIRENTE)" study. Aging Clin Exp Res 2008, 20:234-241.
23. Morris J.N., Fries B.E., Bernabei R., Ikegami N., Gilgen R., Steel K., et al. Home care assessment manual 1996, InterRAI Coporation, Washington, DC.
24. Morris J.N., Fries B.E., Steel K., Ikegami N., Bernabei R., Carpenter G.I., et al. Comprehensive clinical assessment in community setting: applicability of the MDS-HC. J Am Geriatr Soc 1997, 45:1017-1024.
25. Landi F., Tua E., Onder G., Carrara B., Sgadari A., Rinaldi C., et al. Minimum data set for home care: a valid instrument to assess frail older people living in the community. Med Care 2000, 38:1184-1190.
26. Izzotti A., Cartiglia C., Lewtas J., De Flora S. Increased DNA alterations in atherosclerotic lesions of individuals lacking the GSTM1 genotype. FASEB J. 2001, 15:752-757.
27. Miller E.A., Pankow J.S., Millikan R.C., Bray M.S., Ballantyne C.M., Bell D.A., et al. Glutathione-S-transferase genotypes, smoking, and their 3516 association with markers of inflammation, hemostasis, and endothelial function: the atherosclerosis risk in communities (ARIC) study. Atherosclerosis 2003, 171:265-272.
28. Coughlin S.S., Hall I.J. Glutathione S-transferase polymorphisms and risk of ovarian cancer: a HuGE review. Genet Med 2002, 4:250-257.
29. Dong L.M., Potter J.D., White E., Ulrich C.M., Cardon L.R., Peters U. Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA 2008, 299:2423-2436.
30. White D.L., Li D., Nurgalieva Z., El-Serag H.B. Genetic variants of glutathione S-transferase as possible risk factors for hepatocellular carcinoma: a HuGE systematic review and meta-analysis. Am J Epidemiol 2008, 167:377-389.
31. Chenevix-Trench G., Young J., Coggan M., Board P. Glutathione S-transferase M1 and T1 polymorphisms: susceptibility to colon cancer and age of onset. Carcinogenesis 1995, 16:1655-1657.
32. Crofts F., Taioli E., Trachman J., Cosma G.N., Currie D., Toniolo P., et al. Functional significance of different human CYP1A1 genotypes. Carcinogenesis 1994, 15:2961-2963.
33. Cipriano C., Malavolta M., Costarelli L., Giacconi R., Muti E., Gasparini N., et al. Polymorphisms in MT1a gene coding region are associated with longevity in Italian central female population. Biogerontology 2006, 7:357-365.
34. Mocchegiani E., Malavolta M. Zinc-gene interaction related to inflammatory/immune response in aging. Genes Nutr 2008, 3:61-75.